BioMed Research International

Volume 2013 (2013), Article ID 163724, 9 pages

http://dx.doi.org/10.1155/2013/163724

Research Article

Protective Effect of Egyptian Propolis against Rabbit Pasteurellosis

Somia A. Nassar,¹ Amira H. Mohamed,² Hamdy Soufy,¹ and Soad M. Nasr¹

¹Department of Parasitology and Animal Diseases, National Research Center, El-Behouse Street, Dokki, P.O. Box 12622, Giza, Egypt

²Department of Clinical Pathology, Faculty of Veterinary Medicine, Cairo University, P.O. Box 12211, Giza, Egypt

Received 1 April 2013; Revised 21 July 2013; Accepted 24 July 2013

Academic Editor: Stelvio M. Bandiera

Copyright © 2013 Somia A. Nassar et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Abstract.

The present study was conducted to study the protective effect of ethanolic extract of propolis given subcutaneously (S/C) either alone or in combination with inactivated formalized Pasteurella multocida (P. multocida) vaccine in rabbits challenged with virulent P. multocida strain. Twenty-eight New-Zealand rabbits, 6–8 weeks old and not vaccinated against pasteurellosis, were randomly divided into four equal groups. Group (1) was kept as nonvaccinated control. Group (2) was injected S/C with propolis. Group (3) was vaccinated (S/C) with P. multocida vaccine only. Group (4) was injected with vaccine mixed with propolis as adjuvant. Groups (2, 3, and 4) received the same doses of propolis and vaccine after 4 weeks as a booster dose. The experiment continued for six weeks during which clinical signs, body weight, and mortality rate were recorded. Blood samples were collected every 2 weeks of treatment for evaluating the erythrogram and biochemical parameters. At the end of six weeks, all groups were subjected to challenge with a virulent strain of P. multocida. Two weeks later, tissue specimens were collected from different organs for histopathological investigation. Results showed that before challenge all rabbits of different groups were apparently healthy and had good appetite. After challenge, control group (1) showed acute form of the disease, 100% mortality rate, and severe histopathological changes. Rabbits of groups (2 and 3) showed less severe clinical signs, mortality rate, and histopathological changes than control. Rabbits of group (4) were apparently healthy with normal histological picture. In conclusion, an ethanolic extract of propolis injected alone or combined with formalized inactivated P. multocida vaccine improved general health conditions, liver and kidney functions in addition to reduction of the severity of adverse clinical signs, mortality rates, and histopathological changes associated with challenge of rabbits with P. multocida strain.

1. Introduction

One of the most important health problems in rabbit is pasteurellosis, which is considered as a common bacterial disease caused by Pasteurella multocida (P. multocida) and has been reported as a constant serious and highly contagious disease of domestic rabbits [1].

Rabbit pasteurellosis causes symptoms that range from fatal septicemia, severe pleuritis, and pneumonia to less severe sequelae such as multiple abscesses, chronic rhinitis, and otitis media [2]. It mostly affects rabbits at 4–8 weeks of age. Rabbits older than 8 months to 1 year of age showed lower incidence [3].

Pasteurellosis exhibited 3 forms in rabbits. The first one is snuffles or nasal catarrhal inflammation which is characterized by acute, subacute, and chronic inflammation of the air passages and lungs. This form of the disease often ends with death and the cured animals became carriers. The second form is characterized by abscess formation at any part of the body and the case is terminated with septicemia. The last form is characterized by genital infection, which manifests as acute and subacute inflammation of uterus and testicles. Also, rhinitis is the most common clinical manifestation in rabbit pasteurellosis [4–6].

Propolis is a resinous hive product collected by honey bees from exudates and buds of plants and mixed with wax and bee enzymes [7]. Hegazi et al. [8] recorded that the chemical composition of raw Egyptian propolis sample (collected from Dakahlia Governorate) as investigated by GC/MS, 65 compounds were identified, such as aromatic acids: benzoic, cinnamic, trans-p-coumaric, 3,4-dimethoxycinnamic, ferulic, and caffeic acids. Of the 19 esters identified, Egyptian propolis contained 11 caffeate esters including two new to propolis, tetradecenyl caffeate (isomer) and tetradecanyl caffeate. Egyptian propolis contained some new triterpenoids including lupeol and alpha-amyrin. It also contained flavonoids, sugar, and aliphatic acids. The investigators stated that Dakahlia propolis sample was a typical popular propolis. The composition of the propolis depends upon the time, vegetation, and the area of collection [9].

Propolis has several biological and pharmacological properties, as antimicrobial [10], anti-inflammatory [11], antioxidant [12–15], antiparasitic [16], immune modularity and immune stimulant effects and it increased the percentage of protected animals suggesting its use in vaccines as an adjuvant [17, 18].

A reasonable approach to control and eliminate pasteurellosis in rabbits is to develop an improved vaccine as the current experimental vaccines do not provide a complete protection [19].

Therefore, the present work was adopted to evaluate the protective effect of an ethanolic extract of Egyptian propolis when injected S/C alone or in combination with inactivated P. multocida vaccine against experimental challenge of rabbits with P. multocida strain. The study was based on hematological, biochemical, and histopathological investigations.

2. Materials and Methods

This study was carried out according to guidelines for animal experimentation and approved by the Institutional Animal Care and Use Committee, National Research Centre Animal Care Unit, Dokki, Giza, Egypt.

2.1. Animal Used

Twenty-eight male New-Zealand rabbits of 1.5–2 kg body weight and 6–8 weeks old were used in this experiment. Rabbits were not previously vaccinated against pasteurellosis, and bacteriological examination of nasopharyngeal swabs proved that they were free from Pasteurella infection.

2.2. Extraction of Propolis

One hundred grams of the resinous material of Egyptian propolis (obtained from Dakahlia Governorate, Egypt) was cut into small pieces and extracted at room temperature with 50 mL of 70% ethanol. Extraction was performed twice with 24 hours interval. The alcoholic extract was evaporated under vacuum at 50°C until dryness. Obtained dried ethanolic extract of propolis (28 g) was suspended in phosphate buffered saline (PBS) (pH 7.2) [8]. The dose of propolis used in this experiment was 50 mg/kg BW [20].

2.3. Experimental Design

The experiment was carried out at the Experimental Rabbit Unit of Lab Animal House, National Research Center, Dokki, Giza, Egypt. Rabbits were housed in separate cages, fed on a balanced commercial ration, and water was available ad libitum. The animals were assigned into four equal groups which were treated with alcoholic extract of propolis alone or in combination with P. multocida inactivated vaccine (obtained from Veterinary Serum and Vaccine Research Institute, Abbasia, Cairo). Propolis was administrated subcutaneously (S/C) (a single dose of 50 mg/kg B.W.). The vaccine was given as a single S/C dose of 2 mL. Treatment of different rabbit groups was as follows: group (1) was injected S/C with 2 mL sterile phosphate buffer saline solution (PBS) and was kept as normal control, group (2) was injected S/C with a single dose of propolis, group (3) was vaccinated with P. multocida vaccine only, and group (4) was injected S/C with the vaccine mixed with propolis as an adjuvant. Treatments of propolis and vaccine were repeated as a booster dose after four weeks in all groups. The experiment continued for 6 weeks, at the end of which challenge was performed by injection with virulent strain of P. multocida. The strain was obtained from Veterinary Serum and Vaccine Research Institute, Abbasia, Cairo, in the form of lyophilized ampoules. It was activated by culturing in nutrient broth, inoculation in Swiss mice, and reisolation of the organism from heart blood of mice on nutrient agar plates (Difco). Pasteurella colonies were suspended in sterile saline, and the density was adjusted to contain 5 × 10⁹ bacterial cell/mL. The suspension was used for S/C inoculation of rabbits in the challenge test [21].

2.4. Erythrogram and Biochemical Analysis

During the 6 weeks experimentation time, rabbits were weighed and blood samples were collected every 2 weeks. Two blood samples were obtained from the ear vein of each rabbit. The first sample was anticoagulated and used for the determination of the erythrocytes count, packed cell volume, hemoglobin concentration, and red cell indices by using Coulter (MEDONIC CA620). The second sample was collected for serum separation and determination of serum biochemical constituents. The activities of aspartate aminotransferase (AST) and alanine aminotransferase (ALT) [22] and alkaline phosphatase [23] were determined. The concentration of urea [24] and creatinine [25] was estimated. Test kits supplied by bioMérieux-France were used.

2.5. Challenge Test and Pathological Studies

At the end of the experiment (6th week), experimental rabbits were challenged by S/C injection of 0.2 mL/rabbit of broth culture of virulent P. multocida. Re isolation and identification of Pasteurella organisms were done from the heart blood of rabbits died after challenge [21]. Two weeks later after challenge, Postmortem findings were detected, and tissue specimens from heart, trachea, lungs, liver, kidneys, and spleen were collected from dead and sacrificed animals, fixed in 10% formol saline, dehydrated, cleared, and embedded in paraffin blocks. Paraffin sections of 5 μ thickness were prepared, stained by H&E, and examined microscopically for detection of histopathological alterations [26].

2.6. Statistical Analysis

All data were subjected to statistical analysis including the calculation of the mean and standard error. Differences between control and treated groups were tested for significance using a one-way analysis of variance followed by Duncan’s multiple range test. Differences were considered significant at level [27] using SPSS version 10 computer programme.

3. Results

3.1. Clinical Signs

Along the experimental period before challenge, all rabbits of different groups were apparently healthy and had good appetite. During the 1st day after challenge of rabbits with P. multocida strain, rabbits of control group (1) showed acute form of the disease (depression, sneezing, and respiratory manifestations), while some of them showed nervous symptoms and sudden death. Rabbits of groups (2) and (3) showed less severe clinical signs than control group. Some rabbits of group (3) showed superficial multiple abscesses as a chronic form of the disease. Rabbits of group (4) were apparently healthy till time of scarification at the end of the experimental (15 days after challenge (dpc)).

3.2. Mortality Rate

No mortalities were observed in group (4) that administrated propolis with vaccine. Mortalities in group (3) (vaccinated only) represented 28.57% after challenge, but in group (2) (administrated propolis only), mortalities were about 57.14%, while mortalities in control group (1) were about 100%. Most of the mortalities occurred during the 2 dpc.

3.3. Body Weight

No significant changes were demonstrated in the values of body weight of different experimental rabbit groups along the period of the treatment.

3.4. Erythrogram

At the 6th week of treatment, there was a significant decrease in RBCs count and PCV% values, while MCV values exhibited increase in rabbits given vaccine only (group 3) compared to control group (1). Along the period of treatment, no significant changes were demonstrated in the values of Hb content, MCH, and MCHC (Table 1).

Table 1: Erythrogram in different experimental groups of rabbits before and after treatment for six weeks (Mean ± SE, ).

Parameters
Periods (week)
Groups
Sig.

G1

Control
G2

Propolis S/C
G3

Vaccine S/C only
G4

Propolis + Vaccine S/C

RBCs count (10⁶/µL)
0

NS

2

NS

4

NS

6

5.42 ± 0.25ab
4.93 ± 0.45b
5.42 ± 0.20ab
*

Packed cell volume (PCV) (%)
0

NS

2

NS

4

NS

6
34.55 0.53a
33.45 ± 1.16a
29.64 ± 2.51c
31.28 ± 1.37b
*

Hemoglobin (g/dL)
0

NS

2

NS

4

NS

6

NS

Mean corpuscular volume (MCV) (fl)
0

NS

2

NS

4
59.94 ± 0.92b
59.74 ± 0.77b
61.98 ± 1.04a
58.32 ± 1.20b
*

6
58.63 ± 2.20b
59.28 ± 1.41b
62.18 ± 0.78a
60.08 ± 1.37b
*

Mean corpuscular hemoglobin (MCH) (pg)
0

NS

2

NS

4

NS

6

NS

Mean corpuscular hemoglobin concentration (MCHC) (g/dL)
0

NS

2

NS

4

NS

6

34.24± 0.40a
NS

Means with different superscripts in the same row are significantly different at P < 0.05. *P < 0.05, NS: non-significant.

3.5. Serum Biochemistry

Compared to control group, the activity of AST and ALT significantly increased at the 2nd and 4th weeks in group (3), while markedly decreased in the other treated groups all over the experimental period. Changes in ALP activity were less marked in different experimental groups (Table 2).

Table 2: Serum enzymes activities and serum creatinine and urea levels in different experimental groups of rabbits before and after treatment for six weeks (Mean ± SE, ).

Parameters
Periods (week)
Groups
Sig.

G1

Control
G2

Propolis S/C
G3

Vaccine S/C only
G4

Propolis + vaccine S/C

Aspartate amino transferase (IU/L)
0

NS

2
49.71 ± 2.94b
40.96 ± 0.46c
60.73 ± 2.29a
49.11 ± 0.74b
*

4
48.90 ± 0.01b
44.41 ± 1.00c
66.86 ± 2.40a
43.45 ± 0.49c
*

6
51.26 ± 1.87a
43.13 ± 1.47c
50.35 ± 1.90ab
41.16 ± 0.83c
*

Alanine amino transferase (IU/L)
0
54.79 ± 0.82
54.90 ± 3.36
55.70 ± 1.68
56.37 ± 3.26
NS

2
51.91 ± 0.46b
47.60 ± 4.23c
60.45 ± 0.57a
45.40 ± 3.80c
*

4
41.24 ± 3.94c
47.47 ± 3.09b
55.68 ± 1.24a
39.28 ± 1.50c
*

6
53.07 ± 1.23a
40.27 ± 1.91c
47.25 ± 2.75b
39.28 ± 1.50c
*

Alkaline phosphatase (IU/L)
0
15.74 ± 1.23
15.59 ± 2.06

NS

2
16.87 ± 1.02a
15.03 ± 0.29ab
17.59 ± 0.70a
16.39 ± 1.11a
NS

4
15.55 ± 1.35b
14.87 ± 1.55b
20.14 ± 1.17a
15.91 ± 0.90b
*

6

NS

Creatinine (mg/dL)
0

NS

2
1.17 ± 0.08b
0.91 ± 0.04b
1.42 ± 0.01a
0.87 ± 0.04b
*

4
1.07 ± 0.03b
0.76 ± 0.03c
1.39 ± 0.04a
0.76 ± 0.05c
*

6
1.22± 0.27a
0.61 ± 0.03b
1.24 ± 0.02a
0.60 ± 0.03b
*

Urea (mg/dL)
0

NS

2
39.02 ± 1.54a
27.14 ± 1.54d
35.37 ± 0.97b
31.11 ± 1.42c
*

4
39.85 ± 2.21a
24.29 ± 1.06c
32.75 ± 1.67b
29.94 ± 1.22b
*

6
38.15 ± 1.49a
24.23 ± 1.05c
40.14 ± 0.82a
33.25 ± 1.43b
*

Means with different superscripts in the same row are significantly different at P < 0.05. *P < 0.05. NS: nonsignificant.

Serum creatinine and urea levels showed significant decrease throughout the experiment in groups (2) and (4). While group (3) demonstrated significant increase in creatinine level all over the experimental time compared to control group (Table 2).

3.6. Pathological Findings

3.6.1. Postmortem Examination

Rabbits of control group (1) challenged with P. multocida strain showed severe acute form of pasteurellosis. After challenge, rabbits demonstrated severe rhinitis with nasal discharge, congested blood vessels with S/C hemorrhage, presence of blood in thorax and abdomen with severe congestion of trachea, lungs and heart. After 40 hours post challenge rabbits showed congested heart accompanied with enlarged and congested S/C blood vessels, necrotic foci in the liver, brown peritoneum, congested friable kidneys, and dark brown with normal size spleen. Trachea, lungs, and heart were congested, hyperemic and filled with blood. Rabbits administrated propolis only (group 2) showed first deaths after 24 hours after challenge and characterized by sneezing, S/C hyperemic patches, congested heart, trachea and lungs with patches, enlarged and patched liver with necrotic foci, and congested and enlarged spleen. Rabbits administered the vaccine only (group 3) showed less incidence of the disease after challenge represented by presence of multiple lung abscesses, congestion and darkness of the lung and when cut oozing blood, enlarged aorta, and urinary bladder was distended and filled with urine and salts.

Rabbits administered propolis and vaccine (group 4) resisted challenge and were apparently healthy with normal liver, spleen, and heart when scarified at 15 dpc, but some of them showed multiple S/C abscesses in front leg and neck.

3.6.2. Histopathological Findings

Heart of rabbits from different experimental groups, before challenge, showed normal cardiac tissue. Heart of rabbit from group (1) challenged with P. multocida strain, that died within one dpc, showed edema in the pericardium which was infiltrated with inflammatory cells that extended to the myocardium (Figure 1(a)). Heart of rabbit from group (2) that died within 2 dpc showed hydropericardium and hemorrhage between the myocardium muscles (Figure 1(b)). Sections of heart from group (3) and (4) of rabbits, which were sacrificed 15 dpc, showed normal myocardial muscle (Figure 1(c)).

(a)

(b)

(c)

Figure 1: Histopathological changes in the heart of rabbits from different experimental groups. (a) Heart from group (1) rabbits (36 hr pc) showing edema in the pericardium infiltrated with inflammatory cells that extend to the myocardium (H & E ×200). (b) Heart from group (2) rabbits (2 dpc) showing hydropericardium and hemorrhage between the myocardium muscles (H & E ×100). (c) Heart from group (3) rabbits (15 dpc) showing normal myocardial muscle (H & E ×200).

Sections of trachea from rabbits of group (1) which died within 1 dpc showed hyperplasia in the lamina epithelialis and leukocytic infiltration in the lamina propia and submucosa (Figure 2(a)), in addition to marked submucosal edema accompanied with marked congestion of vessels. Trachea from rabbits of group (2), that died 2 dpc, showed degenerated mucosa infiltrated with inflammatory cells and edemated submucosa with congestion (Figure 2(b)). Trachea of rabbits from group (3), which were sacrificed 15 dpc, showed normal mucosa and submucosal edema, hemorrhage, and mononuclear cell infiltration (Figure 2(c)). Trachea of rabbits from group (4), which were sacrificed 15dpc showed normal mucosa with mild edema in the submucosa.

(a)

(b)

(c)

Figure 2: Histopathological changes in the trachea from different experimental groups. (a) Trachea from group (1) rabbits (1 dpc) showing hyperplasia in the lamina epithelialis and leukocytic infiltration in the lamina propia and submucosa. (b) Trachea from group (2) rabbits (2 dpc) showing degenerated mucosa infiltrated with inflammatory cells and edemated submucosa with congestion. (c) Trachea from group (3) rabbits (15 dpc) showing normal mucosa and submucosal edema, hemorrhage, and mononuclear cell infiltration (H & E ×200).

Microscopical examination of lung from group (1) before challenge showed normal histological structure. After challenge, the lungs showed peribronchitis, severely congested vessels with vasculitis, and marked alveolar collapse. Moreover, diffused interstitial inflammatory reaction and giant alveoli were observed (Figure 3(a)). Also edema in the plural sac was noticed. Lung of group (2) after challenge showed chronic venous congestion in the lung tissue (Figure 3(b)), while lungs of group (3) showed vasculitis and mild interstitial inflammatory reaction (Figure 3(c)). Sections from lungs of group (4) which were sacrificed 15dpc showed normal lung tissue.

(a)

(b)

(c)

Figure 3: Histopathological changes in the lung from different experimental groups (a) Lung from group (1) rabbits (1 dpc) showing diffused interstitial inflammatory reaction and giant alveoli. (b) Lung from group (2) rabbits (15 dpc) showing chronic venous congestion in the lung tissue. (c) Lung from group (3) rabbits (15 dpc) showing vasculitis and mild interstitial inflammatory reaction (H & E ×100).

Microscopical examination of liver from group (1) before challenge revealed normal histology of hepatic lobules. After challenge, the liver showed marked portal tract changes in the form of hyperplasia, congested vessels, newly formed bile ductules, and leukocytic infiltration (Figure 4(a)). Liver of rabbits from group (2), which died after challenge, showed focal scattered necrotic nodules infiltrated with leukocytes (Figure 4(b)) and mild bile duct hyperplasia, mild congestion, and mild inflammatory reaction (Figure 4(c)), but liver of rabbits from group (3) 15 dpc showed normal portal area. Sections from liver of group (4) which were sacrificed 15 dpc showed normal hepatic tissue.

(a)

(b)

(c)

Figure 4: Histopathological changes in the liver from different experimental groups (a) Liver from group (1) rabbits (2 dpc) showing marked portal tract changes in the form of hyperplastic bile duct, congested vessels, newly formed bile ductules, and leukocytic infiltration (H & E ×100). (b) Liver from group (2) rabbits (7 dpc) showing focal scattered necrotic nodules infiltrated with leukocytes (H & E ×100). (c) Liver from group (2) rabbits (15 dpc) showing mild bile duct hyperplasia, mild congestion, and mild inflammatory reaction (H & E ×200).

Microscopical examination of kidney from group (1) before challenge showed normal renal tissue, while after challenge the kidney showed congestion in the interstitial blood vessels and glomerular capillaries (Figure 5(a)), in addition to degenerated tubules with formation of renal hyaline cast (Figure 5(b)). Kidneys from group (2) after challenge showed severe vacuolation in the tubules and glomerular tuft (Figure 5(c)). Kidneys from group (3) showed mild vacculation in the tubules and glomerular tafft (Figure 5(d)). Kidneys from group (4) which were sacrificed 15 dpc showed normal renal tissue.

(a)

(b)

(c)

(d)

Figure 5: Histopathological changes in the kidney from different experimental groups. (a) Kidney from group (1) rabbits (1 dpc) showing congestion in the interstitial blood vessels and glomerular capillaries. (b) Kidney from group (1) rabbits (2 dpc) showing degenerated tubules with formation of renal hyaline casts. (c) Kidney from group (2) rabbits (15 dpc) showing severe vacuolation in the tubules and glomerular tuft. (d) Kidney from group (3) rabbits (15 dpc) showing mild vacuolation in the tubules and glomerular tuft (H & E ×200).

Microscopical examination of spleen from group (1) before challenge showed normal lymphoid follicles; in contrast after challenge spleen showed depletion in the lymphoid follicles (Figure 6(a)). In group (2), there was hemorrhage in between the lymphoid follicles at 2 dpc (Figure 6(b)). Spleen from group (3) showed atrophied follicles (Figure 6(c)). Spleen from group (4) which was sacrificed 15 dpc showed normal splenic follicles.

(a)

(b)

(c)

Figure 6: Histopathological changes in the spleen from different experimental groups. (a) Spleen from group (1) rabbits (2 dpc) showing depletion in the lymphoid follicles. (b) Spleen from group (2) rabbits (2 dpc) showing hemorrhage between the lymphoid follicles. (c) Spleen from group (3) rabbits (15 dpc) showing atrophied follicles (H & E ×100).

4. Discussion

The present experiment was conducted to study the effect of an ethanolic extract of propolis given by S/C injection either alone or in combination with inactivated formalized P. multocida vaccine on general performance, erythrogram, biochemical parameters, and pathological lesions induced by challenge of rabbits with virulent P. multocida strain at the end of the experiment.

The symptoms which were observed within one dpc of group (1) with P. multocida strain ranged from severe acute to subacute forms of the disease. Signs of septicemia, acute rhinitis, sneezing, bronchopneumonia, and conjunctivitis and abscess formation agreed with that reported by [1, 2, 28]. These signs were confirmed by macroscopic and microscopic examination of different organs of rabbits of group (1) after challenge. Less severe symptoms observed in group (2) may be due to the effect of propolis as antibacterial, anti-inflammatory, and immunomodularity agent and increase the antibody production [19, 29, 30]. In addition, propolis has broad activities against P. multocida in vitro and in vivo (in the tracheal region of the rabbits) [31]. The chronic form of pasteurellosis, superficial multiple abscesses observed in group (3) may be due to that inactivated vaccine enhance mainly humeral immunity response and immunoglobulins (Ig) level specially IgG [19, 32, 33]. These results were confirmed by the normal microscopic structure of spleen tissue after challenge. Absence of clinical signs in group (4) may be attributed to the synergetic protective effect of both propolis and vaccine. These results agreed with the normal histological structure of different organs in this group.

Mortality rate was 100% in group (1), 57.14% in group (2), and about 28.57% in group (3). Mortality in group (1) may be due to severe septicemia and bronchopneumonia [5, 34], while lower mortalities in group (2) may be attributed to the antibacterial, anti-inflammatory, immune stimulant, and immune modularity effects of propolis [19, 35]. Good protection in group (3) may be attributed to good antibody response and protection induced by the vaccine against experimental challenge with P. multocida [19, 36, 37].

Results of body weight showed no significant difference between all groups along the experimental period.

Results of erythrogram revealed significant decrease in RBCs count, PCV in group (3) which may be due to the cytotoxic effect of vaccine causing inhibition of erythropoiesis [38]. These results agreed with [39].

Regarding serum enzyme activities, AST showed significant gradual decrease in different groups along the period of experiment except group (3) in comparison with control group. This result agreed with Talas and Gulhan [40]. Administration of propolis to rats at a dose of 150–1500 mg/kg BW caused slight inhibition in the activity of aminotransferase enzymes [41]. The demonstrated result in the present study revealed that administration of propolis had no toxic effect on rabbit. A significant decrease in serum ALT level was observed in propolis-treated groups; similar result was observed by Eraslan et al. [42]. No alterations in the activity of AST and ALT in serum of rabbits treated with crude propolis extract [43]. The level of ALP was decreased in group administrated propolis compared to the control group. This decrease may be due to the action of propolis as reducing agent to ALP. These results agreed with Eraslan et al. [42]. Results of liver enzymes activities support that propolis is able to induce hepatoprotective effects which are similar to those of the previous work on propolis that act as hepatoprotective against d-galactosamine, and paracetamol induced liver damage in rats and mice, respectively [44, 45]. The present results were confirmed by absence of histopathological changes in livers of groups (2) and (4) in comparison with liver of control group.

Results of serum creatinine and urea revealed significant decrease in groups (2 and 4) compared to control group. Similar results were recorded by Sforcin et al. [46]. They found that propolis did not induce kidney damage in rats as demonstrated by normal levels of urea and creatinine.

5. Conclusion

ethanolic extract of propolis injected S/C alone or combined with formalized inactivated P. multocida vaccine improved general health conditions, liver and kidney functions in addition to reduction of the severity of adverse clinical signs, mortality rates, and histopathological changes associated with challenge of rabbits with P. multocida strain.

Conflict of Interests

The authors have declared that there is no conflict of interests and there is not any fund for their research.

Acknowledgment

The authors would like to thank Dr. Emad H. Mohamed for his cooperation and help during this work.

References

J. F. Gracy, “Infection of rabbits and horses,” in Meat Hygiene, pp. 482–486, Bailliere Tindall, East Sussex, UK, 8th edition, 1986.

D. H. Percy, J. F. Prescott, and J. L. Bhasin, “Inactivated bacterial antigen were complemented with adjuvents in order to increase the immunogenicity of the vaccines,” Journal of Complementary Medicine, vol. 46, pp. 227–229, 1985.

M. El-Ghawy, The bacteriological flora of respiratory tract of rabbits in health and disease [M.S. thesis Bacteriology], Faculty Veterinary Medicine, Cairo University, 1972.

A. Y. E. Elham, Bacteriological studies on Pasteurella infection in rabbits in Kalubia Governorate [M.S. thesis], Faculty Veterinary Medicine, Banha Branch, Zgzig University, 1972.

T. E. Zimmerman, B. J. Deeb, and R. F. DiGiacomo, “Polypeptides associated with Pasteurella multocida infection in rabbits,” The American Journal of Veterinary Research, vol. 53, no. 7, pp. 1108–1112, 1992.

J. Sandford, Domestic Rabbit, Granada Publishing, London, UK, 5th edition, 1996.

G. A. Burdock, “Review of the biological properties and toxicity of bee propolis (propolis),” Food and Chemical Toxicology, vol. 36, no. 4, pp. 347–363, 1998.

A. G. Hegazi, F. K. Abd El Hady, F. A. El Menway, and H. Al Mehdar, “Egyptian propolis: 5 influence of propolis adminestration on some chicken biochemical parameters,” Journal of Applied Veterinary Science NRC, vol. 1, pp. 43–58, 2004.

A. H. Banskota, Y. Tezuka, I. K. Adnyana et al., “Cytotoxic, hepatoprotective and free radical scavenging effects of propolis from Brazil, Peru, the Netherlands and China,” Journal of Ethnopharmacology, vol. 72, no. 1-2, pp. 239–246, 2000.

F. K. Abd El Hady and A. G. Hegazi, “Egyptian propolis: 2. Chemical composition, antiviral and antimicrobial activities of East Nile Delta propolis,” Zeitschrift fur Naturforschung C, vol. 57, no. 3-4, pp. 386–394, 2002.

E. H. Park and J. H. Kahng, “Suppressive effects of propolis in rat adjuvant arthritis,” Archives of Pharmacal Research, vol. 22, no. 6, pp. 554–558, 1999.

F. D. Marquele, V. M. Di Mambro, S. R. Georgetti, R. Casagrande, Y. M. L. Valim, and M. J. V. Fonseca, “Assessment of the antioxidant activities of Brazilian extracts of propolis alone and in topical pharmaceutical formulations,” Journal of Pharmaceutical and Biomedical Analysis, vol. 39, no. 3-4, pp. 455–462, 2005.

L. Pari and M. Gnanasoundari, “Influence of naringenin on oxytetracycline mediated oxidative damage in rat liver,” Basic and Clinical Pharmacology and Toxicology, vol. 98, no. 5, pp. 456–461, 2006.

K. B. H. Salah, M. A. Mahjoub, J. P. Chaumont et al., “Chemical composition and in vitro antifungal and antioxidant activity of the essential oil and methanolic extract of Teucrium sauvagei Le Houerou,” Natural Product Research, vol. 20, no. 12, pp. 1089–1097, 2006.

M. Kanbur, G. Eraslan, and S. Silici, “Antioxidant effect of propolis against exposure to propetamphos in rats,” Ecotoxicology and Environmental Safety, vol. 72, no. 3, pp. 909–915, 2009.

A. G. Hegazi, F. K. Abd El Hady, and H. A. Shalaby, “An in vitro effect of propolis on adult worms of Fasciola gigantica,” Veterinary Parasitology, vol. 144, no. 3-4, pp. 279–286, 2007.

G. Fischer, M. B. Cleff, L. A. Dummer et al., “Adjuvant effect of green propolis on humoral immune response of bovines immunized with bovine herpesvirus type 5,” Veterinary Immunology and Immunopathology, vol. 116, no. 1-2, pp. 79–84, 2007.

S. A. Nassar, A. H. Mohamed, H. Soufy, S. M. Nasr, and K. M. Mahran, “Effect of propolis as an immunostimulant in rabbits,” The Scientific World Journal, vol. 2012, Article ID 901516, 9 pages, 2012.

Y. S. Lu and S. P. Pakes, “Protection of rabbits against experimental pasteurellosis by a streptomycin-dependent Pasteurella multocida serotype 3:A live mutant vaccine,” Infection and Immunity, vol. 34, no. 3, pp. 1018–1024, 1981.

H. Türkez, M. I. Yousef, and F. Geyikoglu, “Propolis prevents aluminium-induced genetic and hepatic damages in rat liver,” Food and Chemical Toxicology, vol. 48, no. 10, pp. 2741–2746, 2010.

R. Cruickshank, J. P. Duguid, B. P. Marmion, and R. H. A. Swain, Medical Microbiology, vol. 2, Churchill Livingstone, Edinburgh, UK, 12th edition, 1975.

S. M. D. Reitman and S. Frankel, “A colorimetric method for the determination of serum glutamic oxalacetic and glutamic pyruvic transaminases,” The American Journal of Clinical Pathology, vol. 28, no. 1, pp. 56–63, 1957.

N. W. Tietz, Clinical Guide to Laboratory Tests, WB Saunders, Philadelphia, Pa, USA, 3rd edition, 1995.

C. J. Patton and S. R. Crouch, “Spectrophotometric and kinetics investigation of the berthelot reaction for the determination of ammonia,” Analytical Chemistry, vol. 49, no. 3, pp. 465–469, 1977.

O. Houot, Interpretation of Clinical Laboratory Tests, edited by G. Siest, J. Henny, F. Schiele and D. S. Young, Biochemical Publications, 1985.

J. D. Banchroft, A. Stevens, and D. R. Turner, Theory and Practice of Histological Techniques, Churchill Livingstone, New York, NY, USA, 4th edition, 1996.

G. W. Snedecor and W. G. Cochran, Statistical Methods, Iowa State University Press, Ames, Iowa, USA, 8th edition, 1989.

A. Y. E. Elham, Bacteriological studies on Pasteurella infection in rabbits in Kalubia Governorate [M.S. thesis], Faculty of Veterinary Medicine, Zagazig University , Banha Branch, 1992.

F. Hu, H. R. Hepburn, Y. Li, M. Chen, S. E. Radloff, and S. Daya, “Effects of ethanol and water extracts of propolis (bee glue) on acute inflammatory animal models,” Journal of Ethnopharmacology, vol. 100, no. 3, pp. 276–283, 2005.

N. Orsolic and I. Basic, “Immuno-modulation by water-soluble derivatives of propolis: a factor of anti-tumour reactivity,” Journal of Ethnopharmacology, vol. 84, no. 2-3, pp. 265–273, 2003.

R. C. Garcia, M. E. P. de Sá, H. Langoni, and S. R. C. Funari, “Effect of alcohol extract of propolis on Pasteurella multocida in vitro and in rabbits,” Acta Scientiarum—Animal Sciences, vol. 26, no. 1, pp. 69–77, 2004.

B. Borkowska-Opacka, A. Kȩdrak, and M. Truszczyński, “Pasteurella multocida serum level in rabbits vaccinated against pasteruellosis,” Bulletin of the Veterinary Institute in Pulawy, vol. 40, no. 2, pp. 97–104, 1996.

B. Borkowska-Opacka, A. Kȩdrak, and M. Truszczyński, “Application of the ELISA for determination of anti-Pasteurella multocida IgG in the sera of rabbits vaccinated against pasteurellosis under field conditions,” Bulletin of the Veterinary Institute in Pulawy, vol. 41, no. 1, pp. 17–24, 1997.

R. F. DiGiacomo, B. J. Deeb, W. E. Giddens Jr., B. L. Bernard, and M. M. Chengappa, “Atrophic rhinitis in New Zealand white rabbits infected with Pasteurella multocida,” The American Journal of Veterinary Research, vol. 50, no. 9, pp. 1460–1465, 1989.

G. Fischer, F. R. Conceição, F. P. L. Leite et al., “Immunomodulation produced by a green propolis extract on humoral and cellular responses of mice immunized with SuHV-1,” Vaccine, vol. 25, no. 7, pp. 1250–1256, 2007.

L. Okerman and L. Spanoghe, “Protective effects of inactivated pasteurella vaccines in specific pathogen free rabbits,” Comparative Immunology, Microbiology and Infectious Diseases, vol. 4, no. 2, pp. 223–228, 1981.

S. K. Cho, J. M. Park, J. Y. Kim, and Y. D. Yoon, “Studies on the development of combined vaccine for control of snuffles (Pasteurella multocida, Bordetella bronchiseptica infection) in rabbits,” The Research Reports of the Rural Development Administration, vol. 31, no. 3, pp. 29–37, 1989.

Z. Kleinrok, Z. Borzecki, S. Scheller, and W. Matuga, “Biological properties and clinical application of propolis. X. Preliminary pharmacological evaluation of ethanol extract of propolis (EEP),” Arzneimittel-Forschung, vol. 28, no. 2, pp. 291–292, 1978.

I. Jasprica, A. Mornar, Z. Debeljak et al., “In vivo study of propolis supplementation effects on antioxidative status and red blood cells,” Journal of Ethnopharmacology, vol. 110, no. 3, pp. 548–554, 2007.

Z. S. Talas and M. F. Gulhan, “Effects of various propolis concentrations on biochemical and hematological parameters of rainbow trout (Oncorhynchus mykiss),” Ecotoxicology and Environmental Safety, vol. 72, no. 7, pp. 1994–1998, 2009.

A. M. Badawi, Some biochemical effects of the propolis under the normal conditions in rats [M.S. thesis], Faculty of Agriculture, Cairo University, Giza, Egypt, 1990.

G. Eraslan, M. Kanbur, and S. Silici, “Evaluation of propolis effects on some biochemical parameters in rats treated with sodium fluoride,” Pesticide Biochemistry and Physiology, vol. 88, no. 3, pp. 273–283, 2007.

T. T. Oliveira, T. J. Nagem, and J. N. Ribeiro, “Serum activities of aspartate aminotransferase, alanine aminotransferase and gamma glutamyl transpeptidase enzymes in rabbits treated with crude extract of propolis,” Revista de Ciencias Farmaceuticas Basica e Aplicada, vol. 26, no. 1, pp. 25–28, 2005.

Y. Sugimoto, T. Tarumi, Y. Kaneko et al., “Effect of propolis extract on D-galactosamine-induced hepatic injury in rats,” Biological and Pharmaceutical Bulletin, vol. 22, no. 11, pp. 1237–1239, 1999.

S. K. Nirala, M. S. Bhadauria, S. Shukla et al., “Pharmacological intervention of tiferron and propolis to alleviate beryllium-induced hepatorenal toxicity,” Fundamental and Clinical Pharmacology, vol. 22, no. 4, pp. 403–415, 2008.

J. M. Sforcin, E. L. B. Novell, and S. R. C. Funarl, “Seasonal effect of Brazilian propolis on seric biochemical variables,” Journal of Venomous Animals and Toxins, vol. 8, pp. 1–6, 2002.